SEC Form 4 research
| Issuer | RHYTHM PHARMACEUTICALS, INC. |
|---|---|
| Tickers | RYTM, SRYTM |
| Reporting owners | 70 |
| Officers and directors | 15 |
| Last public filing | 2026-09-14 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-14 | 2026-09-14 | Meeker David P | S | 2,300 | $105.19 | Not reported |
| 2026-09-14 | 2026-09-14 | Meeker David P | S | 1,817 | $104.55 | Not reported |
| 2026-09-14 | 2026-09-14 | Meeker David P | S | 8,698 | $103.43 | Not reported |
| 2026-09-14 | 2026-09-14 | Meeker David P | S | 30,746 | $102.35 | Not reported |
| 2026-09-14 | 2026-09-14 | Meeker David P | S | 6,439 | $101.75 | Not reported |
| 2026-09-01 | 2026-08-31 | Smith Hunter C | S | 28,188 | $106.2 | Not reported |
| 2026-09-01 | 2026-08-31 | Smith Hunter C | S | 11,514 | $105.37 | Not reported |
| 2026-09-01 | 2026-08-31 | Smith Hunter C | S | 23,072 | $104.59 | Not reported |
| 2026-08-18 | 2026-08-17 | Joshi Manher | A | 25,000 | $0 | Not reported |
| 2026-08-18 | 2026-08-17 | Joshi Manher | A | 50,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.